Mycobacterium abscessus keratitis after LASIK with IntraLase® femtosecond laser

Ophthalmologica

Volumn 220, Issue 4, 2006, Pages 277-280

  Chung, So Hyang ^a   Mi, In Roh ^a   Min, Soo Park ^a   Young, Tae Kong ^a   Hyung, Keun Lee ^b   Eung, Kweon Kim ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Clarithromycin; IntraLase femtosecond laser; Laser in situ keratomileusis; Moxifloxacin; Mycobacterium abscessus

Indexed keywords

AMIKACIN; CLARITHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PREDNISOLONE ACETATE;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; EYE LAVAGE; FEMALE; HUMAN; KERATITIS; KERATOMILEUSIS; LASER; MYCOBACTERIUM ABSCESSUS; RASH; SIDE EFFECT; VISUAL ACUITY;

ADULT; DIAGNOSIS, DIFFERENTIAL; EQUIPMENT DESIGN; EYE INFECTIONS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATITIS; KERATOMILEUSIS, LASER IN SITU; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; SURGICAL WOUND INFECTION;

EID: 33745441763     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093084     Document Type: Article

References (20)

1. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-659.
2. Seo KY, Lee JB, Lee K, Kim MJ, Choi KR, Kim EK: Non-tuberculous mycobacterial keratitis at the interface after laser in situ keratomileusis. J Refract Surg 2002;18:81-85.
3. Holmes GP, Bond GB, Fader RC, Fulcher SF: A cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 2002;34:1039-1046.
4. Freitas D, Alvarenga L, Sampaio J, Mannis M, Sato E, Sousa L, Vieira L, Yu MC, Martins MC, Hoffling-Lima A, Belfort R: An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003;110:276-285.
5. Chandra NS, Torres MF, Winthrop KL, Bruckner DA, Heidemann DG, Calvet HM, Yakrus M, Mondino BJ, Holland GN: Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol 2001;132:819-830.
6. Chadha R, Grover M, Sharma A, Lakshmy A, Deb M, Kumar A, Mehta G: An outbreak of post-surgical wound infections due to Mycobacterium abscessus. Pediatr Surg Int 1998;13:406-410.
7. Ross BC, Johnson PDR, Oppedisano F, Marino L, Sievers A, Stinear T, Hayman JA, Veitch MG, Robins-Browne RM: Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol 1997;63:4135-4138.
8. Veitch MGK, Johnson PDR, Flood PE, Leslie DE, Street AC, Hayman JA: A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiol Infect 1997;119:313-318.
9. Gremillion DH, Mursch SB, Lerner CJ: Injection site abscesses caused by Mycobacterium chelonei. Infect Cont 1983;4:25-28.
10. Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA: Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;17:197-201.
11. Band JD, Ward JI, Fraser DW, Peterson NJ, Silcox VA, Good RC, Ostroy PR, Kennedy J: Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982;145:9-17.
12. Aghandous R, Zouhdi M, Zizi M, Errami M, Idrissi L: Mycobacterium resistance to antimycobacterial reagent. Therapie 1999;54:623-625.
13. Aubry A, Jarlier V, Escolano S, Truffot-Pernot C, Cambau E: Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 2000;44:3133-3136.
14. Tebas P, Sultan F, Wallace RJ, Fraser V: Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995;20:443-444.
15. Lazarus HM, Imperia PS, Botti RE, Mack RJ, Lass JH: An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents. Lens Eye Toxic Res 1989;6:59-85.
16. Abshire R, Cockrum P, Crider J, Schlech B: Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clin Ther 2004;26:191-196.
17. Kim JY: Nontuberculous mycobacterial keratitis; in Krachmer JH, Mannis MJ, Holland EJ (eds): Cornea, ed 2. Philadelphia, Elsevier Mosby, 2005, vol 1, pp 1035-1042.
18. Kezirian GM, Stonecipher KG: Comparison of the IntraLase femtosecond laser and mechanical keratomes for laser in situ keratomileusis. J Cataract Refract Surg 2004;30:804-811.
19. Dua HS, Singh A, Gomes JA, Laibson PR, Donoso LA, Tyagi S: Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye 1996;10:447-450.
20. Hoffman CJ, Labison PR: Corneal manifestations of local and systemic therapies; in Krachmer JH, Mannis MJ, Holland EJ (eds): Cornea, ed 2. Philadelphia, Elsevier Mosby, 2005, vol 1, pp 887-895.